Skip to content
Search

Latest Stories

Holland & Barrett begins stocking OTC medicines to help ‘customers stay well’

The retailer is trialling a range of over-the-counter medicines and health products in 20 of its stores

UK's health and well-being chain, Holland & Barret (H&B) is trying to widen its customer appeal by stocking a range of branded medicines.


The retailer added a new list of medicines and healthcare products in 20 of its stores as part of a limited trial last month.

The new list includes branded products like cold and cough, painkillers, women's health, gastrointestinal, skin treatments and hayfever.

These exclusive stores now offer a curated selection of products, including E45's skin treatments, Olbas' decongestant oils, and Jungle Formula's insect repellent.

Holland & Barrett spokesperson told Pharmacy Businessthat they want to “enable their customers to take better control of their health and stay well.”

“At Holland & Barrett we’re known for offering a wide range of innovative products to help our customers stay well, however, they’ve told us that sometimes they would like more immediate relief too.

“That’s why we’re trialling a selected range of medicines and healthcare products in around 20 stores, which is a range extension to give our customers more options to take control of their health and wellness,” the spokesperson said.

Medicines and healthcare trial 211 H&B is trialling a range of over-the-counter medicines and health products in 20 of its stores. Credit: The Academy PR

The British multi-national chain traditionally sells specialist health and wellness products, including vitamins, supplements and more recently speciality diets.

However, ever since the owner LetterOne completed a deal to buy back its £700m debt, the retailer has been investing heavily to improve its stores and customer offers.

Michelle Riddalls, CEO of the Proprietary Association of Great Britain (PAGB), commented on strategies to improve the line of products in the stores.

She said: “Holland & Barrett’s decision to widen their portfolio to include over-the-counter medicines is positive news for consumers; this will help even more people to self-care and take ownership of their health and well-being.

“We’re also delighted to announce that Holland & Barrett will be joining PAGB as members.”

As part of its new strategy, H&B is also expanding its presence in areas of the market that relate to its core health and wellness offer.

However, it could threaten the OTC revenue streams of the community pharmacies.

Gareth Jones, NPA Director of Corporate Affairs, said: “The public comes to community pharmacies for a wide range of reasons including the opportunity to get advice and clinical services from a pharmacist, to collect prescription and pharmacy medicines, as well as to purchase OTC medicines.

“Millions of people go to community pharmacies every week and that won’t change significantly with one additional retailer offering OTC medicines.”

More For You

Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
CPCF negotiations conclude: Funding details expected Monday, says CPE

Community pharmacy funding

CPCF negotiations conclude: Funding details expected Monday, says CPE

Community Pharmacy England (CPE) has confirmed the conclusion of Community Pharmacy Contractual Framework (CPCF) negotiations, with funding details for the year ahead expected to be announced on Monday, 31 March.

CPE welcomed the findings of the independent analysis into community pharmacy funding, which played a key role in informing the negotiations.

Keep ReadingShow less